期刊文献+

PTEN和COX-2在髓系白血病中的表达及作用机制探讨 被引量:10

The expression and mechanism of PTEN and COX-2 in myeloid leukemia cells
原文传递
导出
摘要 目的 探讨与张力蛋白同源的10号染色体缺失的磷酸酶基因(phosphatase and tensin hemology deleted on chromosome ten gene,PTEN)及环氧化酶-2(cyclooxygenase-2,COX-2)在髓系白血病细胞中的表达及相互作用.方法 收集2007至2009年保定市第一医院及河北医科大学第二医院住院及门诊患者30例,其中10例慢性粒细胞白血病慢性期(chronic myeloid leukemia-chronic phase,CML-CP)患者、10例慢性粒细胞白血病急变期(chronic myeloid leukemia-blastic crisis,CML-BC)患者及10名健康人,分析所有研究对象骨髓单个核细胞内PTEN、COX-2信使核糖核酸(messenger ribonucleic acid,mRNA)表达水平变化.将携带有野生型PTEN和绿色荧光蛋白的腺病毒(Ad-PTEN-GFP)及对照载体腺病毒(Ad-GFP)转染人慢性粒细胞白血病(chronic myeloid leukemia,CML)细胞系K562.流式细胞仪检测转染效率;四甲基偶氮唑蓝(3-[4,5-dimethyl-2-thiazolyl]-2,5-dip,MTT)法检测细胞增殖抑制率及黏附功能;荧光定量聚合酶链反应(polymerase chain reaction,PCR)检测PTEN、COX-2 mRNA水平变化,蛋白质印迹(western blot,WB)检测PTEN、p-Akt蛋白表达水平的变化,细胞化学染色检测COX-2蛋白表达变化.结果 CML-BC患者中PTEN mRNA表达水平(0.022 ±0.021)低于CML-CP(1.134±1.124)及健康对照组(1.059±0.595,F=7.16,P<0.01),而COX-2 mRNA在CML-BC(0.761 ±0.418)患者中均高于CML-CP(0.211 ±0.158)及健康对照组(0.165±0.152,F=12.58,P<0.01).以MOI=200转染K562细胞后,Ad-PTEN-GFP组K562细胞最大增殖抑制率为38.67% ±4.30%,明显高于Ad-GFP组抑制率(5.34%±0.31%,t=13.39,P<0.01),转染3d后Ad-PTEN-GFP组K562细胞内COX-2 mRNA表达水平(0.013 ±0.001)均明显低于Ad-GPF组(0.199±0.018)及未转染组COX-2 mRNA(0.217 ±0.021,F=499.45,P<0.01).p-Akt及COX-2蛋白表达水平亦明显减低.结论 PTEN可能通过抑制COX-2表达从而抑制白血病细胞增殖、黏附功能. Objective To investigate expression and regulatory mechanism of phosphatase and tensin hemology deleted on chromosome ten gene (PTEN) and cyclooxygenase-2 (COX-2) in human myeloid leukemia cells.Methods Thirty patients was collected from the First Hospital of Baoding and Second Affiliated Hospital of Hebei Medical University,including 10 chroni myeloid leukemiac (CML)patients in chronic phase (CML-CP),10 CML patients in blast crises (CML-BC) and 10 normal controls.The recombinated adenovirus containing green fluorescent protein (GFP) and PTEN ( Ad-PTEN-GFP) or empty vector (Ad-GFP) was transfected into human CML K562 cells.The growth of K562 cells and cell adhesion ability was observed by 3-[4,5-dimethyl-2-thiazolyl]-2,5-dip (MTF) assay; PTEN and COX-2 messenger ribonucleic acid (mRNA) levels were detected by real-time fluorescent relative-quantification reverse transcriptional PCR (FQ-PCR).PTEN and p-Akt protein levels were detected by western blot,and COX-2 protein were measured with cytochemical staining.Results The mRNA expression levels of PTEN in CML-BC patients (0.022 ±0.021 ) were lower than CML-CP patients (1.134 ± 1.124) and normal control ( 1.059 ±0.595).The mRNA expression levels of COX-2 in CML-BC patients (0.761 ±0.418) were higher than CML-CP (0.211 ± 0.158) and normal control (0.165 ± 0.152).The growth of K562 cells was suppressed markedly,and the maximum growth inhibition rate was 38.67% ± 4.30% after transfected with PTEN gene,which was higher than Ad-GFP group (5.34% ±0.31%,t =13.39,P 〈0.01 ).COX-2 mRNA expression levels in Ad-PTEN-GFP(0.013 ± 0.001 )were significantly lower than Ad-GFP group (0.199 ±0.018) and untransfected group (0.217 ± 0.021,F =499.45,P 〈 0.01 ),and p-Akt as well as COX-2protein were also down-regulated after K562 cells transfected ( MOI =200) with wild type PTEN in three days.Conclusion PTEN may inhibit proliferation and adhesion ability of leukemia cell in myeloid leukemia via down-regulating COX-2 expression.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2012年第2期165-169,共5页 Chinese Journal of Laboratory Medicine
基金 基金项目:河北省自然基金资助项目(C2010000538) 保定市科技攻关计划项目(11ZF003)
关键词 白血病 髓样 加速期 PTEN磷酸水解酶 环氧化酶2 Leukemia,myeloid,accelerated phase PTEN phosphohydrolase Cyclooxygenase 2
  • 相关文献

参考文献12

  • 1Secchiero P, Barbarotto E, Gonelli A, et al. Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells.Am J Pathol,2005,167:1599-1607.
  • 2Atik E, Akansu B, Bakaris S, et al. Expression of cyclooxygenase-2 and its relation to histological grade,inducible nitric oxide synthase, matrix metalloproteinase-2, CD-34,Caspase-3,and CD8 in invasive ductal carcinoma of the breast Saudi Med J,2010,31:130-134.
  • 3St-Germain ME,Gagnon V,Mathieu 1,et al.Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.Int J Oncol,2004,24:1311-1324.
  • 4Chu EC,Chai J,Tarnawski AS.NSAIDs activate PTEN and other phosphatases in human colon cancer cells:novel mechanism for chemopreventive action of NSAIDs. Biochem Biophys Res Commun,2004,320:875-879.
  • 5成志勇,郭晓玲,李世辉,王素云,杨晓阳,薛芳,温树鹏,潘崚.PTEN-FAK信号传导通路在白血病细胞迁移、侵袭中的作用[J].中华血液学杂志,2009,30(2):115-120. 被引量:29
  • 6Jotta PY,Ganazza MA,Silva A,et al.Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia.Leukemia,2010,24:239-242.
  • 7Yang J,Liu J,Zheng J,et al.A reappraisal by quantitative flow cytometry analysis of PTEN expression in acute leukemia.Leukemia,2007,21:2072-2074.
  • 8成志勇,万建设,王亚丽,梁丽青,梁文同,穆敬,芦希,潘崚.PTEN基因对慢性粒细胞白血病Survivin、Xiap、Smac调控的研究[J].中华医学杂志,2011,91(40):2868-2872. 被引量:13
  • 9Montiel-Duarte C,Cordeu L,Agile X,et al. Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation.Leuk Res,2008,32:709-716.
  • 10Honjo S,Osaki M,Ardyanto TD,et al. COX-2 inhibitor,NS398,enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines. DNA Cell Biol,2005,24:141-147.

二级参考文献33

  • 1成志勇,潘崚,牛志云,梁文同,贾志强,颜晓燕,姚丽,杨敬慈.PTEN基因转染对白血病细胞VEGF调控作用的影响[J].肿瘤,2010,30(10):815-821. 被引量:17
  • 2Myers MP, Stolarov JP, Eng C,et al. PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A, 1997,94:9052-9057.
  • 3Tamura M, Gu J, Matsumoto K, et al. Inhibition of cell migration, spreading,and local adhesions by tumor suppressor PTEN. Science, 1998, 280:1614-1617.
  • 4Dahia PL, Aguiar RC, Alberta J,et al. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Hum Mol Genet, 1999, 8 : 185-193.
  • 5Yilmaz OH, Valdez R, Theisen BK, et al. Pten dependence distinguishes haematopoietic stem cells from leukemia-initiating cells. Nature, 2006, 441:475-482.
  • 6Yang J, Liu J, Zheng J,et al. A reappraisal by quantitative flow cytometry analysis of PTEN expression in acute leukemia. Leukemia, 2007, 21:2072-2074.
  • 7Cheong JW, Eom JI, Maeng HY, et al. Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome. Br J Haernatol,2003,122:454-456.
  • 8Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, et al. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood, 2004, 1048 : 2492-2498.
  • 9Xn Q,Simpson SE,Scialla TJ,et at. Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood, 2003, 102 : 972-980.
  • 10Recher C, Ysebaert L, Beyne-Rauzy O, et al. Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis. Cancer Res, 2004, 64:3191-3197.

共引文献40

同被引文献84

  • 1宋艳斌,马文丽,冯春琼,毛向明,石嵘,张宝,郑文岭.应用RNA干扰技术抑制K562细胞BCR-ABL基因表达及诱导细胞凋亡[J].基础医学与临床,2005,25(7):620-623. 被引量:6
  • 2成志勇,潘崚,牛志云,梁文同,贾志强,颜晓燕,姚丽,杨敬慈.PTEN基因转染对白血病细胞VEGF调控作用的影响[J].肿瘤,2010,30(10):815-821. 被引量:17
  • 3王滔明,许建明,胡乃中.Survivin、COX-2和VEGF在胃癌中的表达及其与预后的意义[J].临床消化病杂志,2007,19(1):35-39. 被引量:8
  • 4GARZON R, VOLINIA S, LIU C G, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia [ J ] . Blood, 2008, 111 (6): 3183-3189.
  • 5POPOVIC R, RIESVECK L E. VELU C S, et al. Regulation of miR-196b by MLL and its overexpression by MLL filsions contributes to immortalization [J ] . Blood, 2009, 113(14): 3314-3322.
  • 6LIU Y, SONG Y B, MAW L, et al. Decreased microRNA-30a levels are associated with enhanced ABL1 and BCR-ABL1 expression in chronic myeloid leukemia [J]. Leuk Res,2013, 37 (3): 349-356.
  • 7ALTIERI D C. Survivin and apoptosis control [ J ] . Adv Cancer Res, 2003, 88: 31-52.
  • 8IBRAHIM A M, MANSOUR I M, WILSON M M, et al. Study of survivin and X-linked inhibi|or of apoptosis protein (XIAP) genes in acute myeloid leukemia (AML) [ J ] . Lab Hematok 2012, 18(1): 1-10.
  • 9CARTER B Z, QIU Y, HUANG X, et al. Survivin is highly expressed in CD34 (+) 38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML [ J ] . Blood, 2012, 120(1): 173-180.
  • 10方志鸿.survivin在BCR/ABL转化白血病细胞中的表达调控、作用与治疗策略的研究[DB/OL].http://d.g.wanfangdata.com.cn/Thesis-Y1414251.aspx,2009-04-29/2012-12-17.

引证文献10

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部